NFL Biosciences has given holders of its first warrants until December 17 to subscribe for new shares at €0.30 each. The Montpellier company’s issuer notice says three A warrants buy one new share and also deliver one B warrant. The second warrant can buy one further share at €0.80 during a separate window next year.
Two deadlines for the first warrant
The programme allocates one A warrant free for each existing share held by eligible shareholders. The issuer lists November 23 after market close as the record date and November 24 as the delivery and first exercise day. A warrants are scheduled to trade through December 15 and remain exercisable through December 17. New shares subscribed through A warrants are scheduled to settle on January 4, 2027. B warrants are scheduled to trade January 4 through June 15, 2027 and remain exercisable through June 17. Investors can check their broker’s earlier instruction cutoffs and any eligibility restrictions.
The exercise price is separate from any price paid to buy a warrant in the market. Exercising three A warrants uses €0.30 in cash plus any applicable charges or acquisition cost. Investors can compare the exercise terms and the value of the B warrant received with the underlying share quotation. Both warrants can expire unused.
What full takeup would do to ownership
The company reports 13,832,046 existing shares and a maximum of 4,610,682 new shares at each stage. If every A warrant is exercised, an investor holding the same number of shares would retain 75% of their former percentage ownership. With full takeup in both stages, the investor would retain 60% of their former stake, a 40% relative decline. A 1% stake would become 0.6% in that scenario. Actual dilution and the approximately €5.07 million maximum gross proceeds depend on how many warrants are exercised.
The FOLITIC warrants and rights guide covers exercise prices, subscription windows and dilution.
Archival photograph. Vpe via Wikimedia Commons. CC0 1.0. Displayed at a reduced size.



